MarkWide Research

Sale!

Neurovascular Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Neurovascular Devices Market size surpassed USD 3 billion in 2021 and is expected to witness over 5.8% CAGR from 2022 to 2028. Rising prevalence of neurological disorders coupled with a growing demand for effective neurovascular devices are expected to drive the market growth over the forecast period. For instance, according to the World Stroke Organization, nearly 2.7 million people die from ischemic stroke every year, with people under the age of 70 accounting for one-quarter of all deaths.

Moreover, growing technological advancement in neurovascular treatments is expected to drive the market statistics. However, high cost of neurovascular devices and lack of skilled professionals are the major restraining factors for the market growth. Additionally, the COVID-19 pandemic has a moderate impact on the market as, amid the pandemic, a vast majority of elective brain surgeries were postponed to free-up limited space for people being treated for the virus. Furthermore, hospital admissions began to fall in March 2020, as hospitals postponed elective admissions and treatments. Also, physicians shifted their focus away from in-person care to telemedicine and many people also put off getting medical help.

A surging number of neurovascular disorders in developed region is expected to accelerate market revenue

Rising incidences of neurological and cerebrovascular diseases such as brain aneurysms and ischemic strokes will render positive impact on the market demand. Additionally, the rapidly growing aging population and large population base suffering from ischemic stroke is another major factor driving the market statistics. For instance, according to the American Association of Neurological Surgeons, approximately 700,000 people suffer from stroke every year, about 500,000 of these are first attacks and 200,000 are victims of repeated attacks. Within five years, almost 25% of individuals who recover from their first stroke will have another. Such a scenario is expected to drive the demand for neurovascular devices in the U.S.
When blood supply to a part of the brain is blocked, an ischemic stroke occurs. The block is usually caused by a blood clot that gets stuck in a narrow blood vessel. This blood clot causes loss of body functions controlled by that area of the brain. Thus, to avoid such situations neurosurgeons use several neurovascular devices such as neurovascular thrombectomy device. This device is useful in eliminating the blood clots accumulated in the neurovascular vessels during an acute ischemic stroke. Such scenarios will propel the market trends.

Growing adoption of embolic coils provide numerous growth opportunities for neurovascular devices industry growth

Based on the product, the neurovascular devices market is categorized into embolic protection devices, embolic coils, intracranial stents, intrasaccular devices, catheters, carotid stents, flow diverters, neurothrombectomy devices, balloon systems, stent retrievers, guidewires, and others. Out of these, embolic coils segment accounted for around 17.5% market share in 2021 owing to increasing prevalence of brain aneurysm and ischemic stroke in the developed countries. Additionally, surge in demand for minimally invasive procedures such as coil embolization will further boost demand for embolic coils in the future.
Embolization coils and occlusion devices are also used to successfully eliminate the residual central aorta to pulmonary artery in adults who are at high or prohibitive surgical risk. The embolic coiling is also used to treat a condition called arteriovenous malformation (AVM). An AVM is an abnormal connection between an artery and a vein. It may happen in the brain, spinal cord, or elsewhere in the body. Thus, increasing adoption of embolic coil will be beneficial for the industry expansion.

Increasing number of novel product launches by key players will positively promote neurothrombectomy segment demand

By process, the neurovascular devices market is segmented into stenting, neurothrombectomy, cerebral angiography, microsurgical clipping, carotid endarterectomy, coiling, flow diversion and others. Among them, the neurothrombectomy segment accounted for over USD 355 million in 2021. Neurothrombectomy devices are used to destroy blood clots in the cerebral microvasculature. The neurothrombectomy surgery is the most preferred treatment for acute ischemic stroke because it improves functional results and lowers the death rate. Additionally, increasing number of product launches by the key players will also propel the market growth.
For instance, in 2019, Medtronic announced the launch of the Solitaire X revascularization device. This device is useful in removing the blood clots present in brain. Furthermore, the use of clot retrievers has increased in elderly patients (aged 55 to 65) due to the growing incidence of stroke. Such scenarios will positively promote the market outlook.

Rising cases of brain aneurysm in old age people will boost the segmental statistics

Based on therapeutic applications, the neurovascular devices industry is categorized brain aneurysm, stenosis, ischemic strokes, and others. The brain aneurysm segment accounted for over 37.9% market share in 2021. The growth of the segment is attributed to rising cases of brain aneurysm in geriatric population. Other major factors that lead to the development of brain aneurysms include smoking, high blood pressure, and a family history of aneurysms. To treat this medical condition several invasive treatments are available such as flow diverters, and tubular stent-like implants. These neurovascular devices aid in the diversion of blood flow away from the aneurysm sac. The diversion blocks blood flow within the aneurysm, causing the body to repair the wound and encourage arterial rebuilding in the patient. Larger aneurysms that cannot be safely treated with other methods may benefit from flow diverters. Such scenarios will fuel market growth.

Increasing demand for minimally invasive procedures will propel the hospital segment expansion

The neurovascular devices market, based on end-use, is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospital segment accounted for around USD 1.5 billion in 2021. The hospital segment growth is high due to higher adoption rate of neurovascular devices in the hospitals, as there is rise in number of patient population suffering with neurovascular disorders. Additionally, there has been an increase in number of hospitals that strive to provide comprehensive treatment options for various brain and spine disorders generating a huge demand for neurovascular devices. These hospitals are equipped with a variety of advanced minimally invasive treatments such as endovascular coiling, stenting, embolization and microsurgical repair and resections.

North America dominates the overall market outlook

North America neurovascular devices market captured around 34.7% market share in 2021 and is poised to grow substantially during the forthcoming years. High regional growth is attributed to increasing prevalence of ischemic strokes along with rising number of surgeries. Moreover, surge in funding for advanced healthcare research, increasing per capita healthcare expenditure and implementation of favorable reimbursement policies will further boost regional market statistics.
Furthermore, the region is witnessing several industry hospital collaborations and the presence of major players operating in this industry leads to easy availability of neurovascular devices. Such aforementioned factors foster the regional industry expansion.

Innovative approach by key market players will upraise growth opportunities in neurovascular devices market

Some of the key market players operating in the neurovascular devices industry include, Asahi Intecc CO., LTD., Boston Scientific Corporation, Integer Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Medix Corp., LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Penumbra, Inc., Stryker, and Terumo Corporation. These industry participants are formulating various growth strategies with continued innovations and technology improvements to sustain industry competition in the market.

Some of the recent industry developments:

  • In July 2021, Terumo Medical Corporation (TMC) announced the launch of AZUR Vascular Plug. It is the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. Such advanced product launches helped company in strengthening its market position.
  • In December 2020, MicroPort Scientific Corporation, received China’s National Medical Products Administration (NMPA) a registration certificate for Bridge Vertebral Drug-Eluting Stent for the treatment of symptomatic vertebral artery stenosis. This product launch helped the company in enhancing its overall product range.

The neurovascular devices report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Product

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Catheters
  • Embolic Protection Devices
  • Flow Diverters
  • Neurothrombectomy Devices
  • Intrasaccular Devices
  • Balloon Systems
  • Stent Retrievers
  • Guidewires
  • Others

By Process

  • Neurothrombectomy Procedure
  • Cerebral Angiography Technique
  • Carotid Endarterectomy (CEA)
  • Stenting
  • Microsurgical Clipping
  • Coiling
  • Flow Diversion
  • Others

By Therapeutic Application

  • Brain Aneurysm
  • Stenosis
  • Ischemic Strokes
  • Others

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Turkey
    • Netherlands
    • Belgium
    • Austria
    • Switzerland
    • Poland
    • Czech Republic
    • Hungary
    • Portugal
    • Greece
    • Romania
    • Bulgaria
    • Denmark
    • Sweden
    • Norway
    • Finland
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Korea
    • Singapore
    • Hong Kong
    • Taiwan
    • Indonesia
    • Cambodia
    • Philippines
    • Vietnam
    • Malaysia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Neurovascular devices industry 360º synopsis, 2017 – 2028

2.2    Business trends

2.3    Product trends

2.4    Process trends

2.5    Therapeutic application trends

2.6    End-use trends

2.7    Regional trends

Chapter 3   Neurovascular Devices Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 – 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing number of brain aneurysm and ischemic strokes in North America

3.3.1.2    Rising demand for minimally invasive surgical procedures

3.3.1.3    Technological advancement in neurovascular treatments

3.3.1.4    Government initiatives to modernize healthcare infrastructure across the globe

3.3.2    Industry pitfalls and challenges

3.3.2.1    Need for designing more effective and low-cost treatments

3.3.2.2    Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By process

3.4.3    By therapeutic application

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Regulatory and reimbursement landscape

3.7.1    U.S.

3.7.2    Europe

3.7.3    China

3.8    Competitive landscape, 2021

3.8.1    Company matrix analysis, 2021

3.9    PESTEL analysis

Chapter 4   Neurovascular Devices Market, By Product

4.1    Key segment trends

4.2    Embolic Coils

4.2.1    Market size, by region, 2017 – 2028 (USD Million)

4.2.2    Market size, by region, 2017 – 2028 (000’ Units)

4.3    Carotid Stents

4.3.1    Market size, by region, 2017 – 2028 (USD Million)

4.3.2    Market size, by region, 2017 – 2028 (000’ Units)

4.4    Intracranial Stents

4.4.1    Market size, by region, 2017 – 2028 (USD Million)

4.4.2    Market size, by region, 2017 – 2028 (000’ Units)

4.5    Catheters

4.5.1    Market size, by region, 2017 – 2028 (USD Million)

4.5.2    Market size, by region, 2017 – 2028 (000’ Units)

4.6    Embolic Protection Devices

4.6.1    Market size, by region, 2017 – 2028 (USD Million)

4.6.2    Market size, by region, 2017 – 2028 (000’ Units)

4.7    Flow Diverters

4.7.1    Market size, by region, 2017 – 2028 (USD Million)

4.7.2    Market size, by region, 2017 – 2028 (000’ Units)

4.8    Neurothrombectomy Devices

4.8.1    Market size, by region, 2017 – 2028 (USD Million)

4.8.2    Market size, by region, 2017 – 2028 (000’ Units)

4.9    Intrasaccular Devices

4.9.1    Market size, by region, 2017 – 2028 (USD Million)

4.9.2    Market size, by region, 2017 – 2028 (000’ Units)

4.10    Balloon Systems

4.10.1    Market size, by region, 2017 – 2028 (USD Million)

4.10.2    Market size, by region, 2017 – 2028 (000’ Units)

4.11    Stent Retrievers

4.11.1    Market size, by region, 2017 – 2028 (USD Million)

4.11.2    Market size, by region, 2017 – 2028 (000’ Units)

4.12    Guidewires

4.12.1    Market size, by region, 2017 – 2028 (USD Million)

4.12.2    Market size, by region, 2017 – 2028 (000’ Units)

4.13    Others

4.13.1    Market size, by region, 2017 – 2028 (USD Million)

4.13.2    Market size, by region, 2017 – 2028 (000’ Units)

Chapter 5   Neurovascular Devices Market, By Process

5.1    Key segment trends

5.2    Neurothrombectomy Procedure

5.2.1    Market size, by region, 2017 – 2028 (USD Million)

5.3    Cerebral Angiography Technique

5.3.1    Market size, by region, 2017 – 2028 (USD Million)

5.4    Carotid Endarterectomy (CEA)

5.4.1    Market size, by region, 2017 – 2028 (USD Million)

5.5    Stenting

5.5.1    Market size, by region, 2017 – 2028 (USD Million)

5.6    Microsurgical Clipping

5.6.1    Market size, by region, 2017 – 2028 (USD Million)

5.7    Coiling

5.7.1    Market size, by region, 2017 – 2028 (USD Million)

5.8    Flow Diversion

5.8.1    Market size, by region, 2017 – 2028 (USD Million)

5.9    Others

5.9.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 6   Neurovascular Devices Market, By Therapeutic Application

6.1    Key segment trends

6.2    Brain Aneurysm

6.2.1    Market size, by region, 2017 – 2028 (USD Million)

6.3    Stenosis

6.3.1    Market size, by region, 2017 – 2028 (USD Million)

6.4    Ischemic Strokes

6.4.1    Market size, by region, 2017 – 2028 (USD Million)

6.5    Others

6.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 7   Neurovascular Devices Market, By End-use

7.1    Key segment trends

7.2    Hospitals

7.2.1    Market size, by region, 2017 – 2028 (USD Million)

7.3    Ambulatory Surgical Centers

7.3.1    Market size, by region, 2017 – 2028 (USD Million)

7.4    Clinics

7.4.1    Market size, by region, 2017 – 2028 (USD Million)

7.5    Others

7.5.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 8   Neurovascular Devices Market, By Region

8.1    Key regional trends

8.2    North America

8.2.1    Market size, by country, 2017 – 2028 (USD Million)

8.2.2    Market size, by country, 2017 – 2028 (000’ Units)

8.2.3    Market size, by product, 2017 – 2028 (USD Million)

8.2.4    Market size, by product, 2017 – 2028 (000’ Units)

8.2.5    Market size, by process, 2017 – 2028 (USD Million)

8.2.6    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.2.7    Market size, by end-use, 2017 – 2028 (USD Million)

8.2.8    U.S.

8.2.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.2.8.2    Market size, by product, 2017 – 2028 (000’ Units)

8.2.8.3    Market size, by process, 2017 – 2028 (USD Million)

8.2.8.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.2.8.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.2.9    Canada

8.2.9.1    Market size, by product, 2017 – 2028 (USD Million)

8.2.9.2    Market size, by product, 2017 – 2028 (000’ Units)

8.2.9.3    Market size, by process, 2017 – 2028 (USD Million)

8.2.9.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.2.9.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3    Europe

8.3.1    Market size, by country, 2017 – 2028 (USD Million)

8.3.2    Market size, by country, 2017 – 2028 (000’ Units)

8.3.3    Market size, by product, 2017 – 2028 (USD Million)

8.3.4    Market size, by product, 2017 – 2028 (000’ Units)

8.3.5    Market size, by process, 2017 – 2028 (USD Million)

8.3.6    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.7    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.8    Germany

8.3.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.8.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.8.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.8.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.8.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.9    France

8.3.9.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.9.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.9.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.9.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.9.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.10    UK

8.3.10.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.10.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.10.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.10.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.10.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.11    Italy

8.3.11.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.11.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.11.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.11.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.11.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.12    Spain

8.3.12.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.12.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.12.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.12.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.12.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.13    Russia

8.3.13.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.13.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.13.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.13.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.13.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.14    Turkey

8.3.14.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.14.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.14.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.14.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.14.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.15    Netherlands

8.3.15.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.15.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.15.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.15.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.15.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.16    Belgium

8.3.16.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.16.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.16.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.16.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.16.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.17    Austria

8.3.17.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.17.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.17.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.17.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.17.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.18    Switzerland

8.3.18.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.18.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.18.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.18.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.18.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.19    Poland

8.3.19.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.19.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.19.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.19.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.19.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.20    Czech Republic

8.3.20.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.20.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.20.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.20.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.20.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.21    Hungary

8.3.21.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.21.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.21.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.21.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.21.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.22    Portugal

8.3.22.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.22.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.22.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.22.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.22.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.23    Greece

8.3.23.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.23.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.23.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.23.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.23.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.24    Romania

8.3.24.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.24.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.24.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.24.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.24.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.25    Bulgaria

8.3.25.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.25.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.25.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.25.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.25.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.26    Denmark

8.3.26.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.26.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.26.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.26.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.26.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.27    Sweden

8.3.27.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.27.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.27.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.27.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.27.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.28    Norway

8.3.28.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.28.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.28.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.28.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.28.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.3.29    Finland

8.3.29.1    Market size, by product, 2017 – 2028 (USD Million)

8.3.29.2    Market size, by product, 2017 – 2028 (000’ Units)

8.3.29.3    Market size, by process, 2017 – 2028 (USD Million)

8.3.29.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.3.29.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4    Asia Pacific

8.4.1    Market size, by country, 2017 – 2028 (USD Million)

8.4.2    Market size, by country, 2017 – 2028 (000’ Units)

8.4.3    Market size, by product, 2017 – 2028 (USD Million)

8.4.4    Market size, by product, 2017 – 2028 (000’ Units)

8.4.5    Market size, by process, 2017 – 2028 (USD Million)

8.4.6    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.7    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.8    Japan

8.4.8.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.8.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.8.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.8.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.8.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.9    China

8.4.9.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.9.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.9.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.9.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.9.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.10    India

8.4.10.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.10.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.10.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.10.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.10.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.11    Australia

8.4.11.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.11.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.11.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.11.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.11.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.12    Korea

8.4.12.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.12.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.12.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.12.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.12.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.13    Singapore

8.4.13.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.13.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.13.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.13.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.13.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.14    Hong Kong

8.4.14.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.14.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.14.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.14.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.14.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.15    Taiwan

8.4.15.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.15.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.15.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.15.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.15.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.16    Indonesia

8.4.16.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.16.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.16.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.16.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.16.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.17    Cambodia

8.4.17.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.17.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.17.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.17.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.17.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.18    Philippines

8.4.18.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.18.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.18.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.18.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.18.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.19    Vietnam

8.4.19.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.19.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.19.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.19.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.19.5    Market size, by end-use, 2017 – 2028 (USD Million)

8.4.20    Malaysia

8.4.20.1    Market size, by product, 2017 – 2028 (USD Million)

8.4.20.2    Market size, by product, 2017 – 2028 (000’ Units)

8.4.20.3    Market size, by process, 2017 – 2028 (USD Million)

8.4.20.4    Market size, by therapeutic application, 2017 – 2028 (USD Million)

8.4.20.5    Market size, by end-use, 2017 – 2028 (USD Million)

<p st

By Product

  • Embolic Coils
  • Carotid Stents
  • Intracranial Stents
  • Catheters
  • Embolic Protection Devices
  • Flow Diverters
  • Neurothrombectomy Devices
  • Intrasaccular Devices
  • Balloon Systems
  • Stent Retrievers
  • Guidewires
  • Others

By Process

  • Neurothrombectomy Procedure
  • Cerebral Angiography Technique
  • Carotid Endarterectomy (CEA)
  • Stenting
  • Microsurgical Clipping
  • Coiling
  • Flow Diversion
  • Others

By Therapeutic Application

  • Brain Aneurysm
  • Stenosis
  • Ischemic Strokes
  • Others

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Asahi Intecc CO., LTD., Boston Scientific Corporation, Integer Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Medix Corp., LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Penumbra, Inc., Stryker, and Terumo Corporation.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF